HD Labs Tirzepatide 30mg/vial

R 1,500.00
Add to WishlistCompare

Product Overview

Tirzepatide 30 by HD Labs is a high-purity synthetic peptide formulated for laboratory and in-vitro research applications. As a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist, this compound is widely studied for its role in metabolic and endocrine research. Each vial contains 30mg of lyophilized peptide, manufactured under HD Labs' quality-controlled processes and supplied with an authenticity verification system for research integrity.

This product is intended strictly for laboratory research purposes. It is not for human or animal consumption, diagnostic use, or therapeutic application.

Composition

  • Active Compound: Tirzepatide (GIP/GLP-1 receptor agonist)
  • Concentration: 30mg per vial
  • Form: Lyophilized powder
  • Purity: Manufactured to research-grade standards
  • Packaging: Sterile single-use vial

    Research Overview

    Tirzepatide is a synthetic peptide investigated in scientific literature for its dual-incretin mechanism, engaging both GIP and GLP-1 receptor pathways. Research interest centers on its influence on glucose homeostasis, insulin secretion pathways, and energy metabolism in laboratory models. As a novel dual-agonist molecule, it continues to be a subject of ongoing academic and pharmaceutical research into incretin-based signaling.

    Don't forget your bacteriostatic water!
    This product is supplied as a lyophilized (freeze-dried) powder and requires bacteriostatic water for reconstitution before research use. Shop our 10mL BAC Water →


Key Features

Product Features

  • 30mg concentration per vial for extended research use
  • Manufactured under HD Labs' licensed laboratory standards
  • Tamper-evident packaging with scratch-and-scan authenticity verification
  • Store-and-protect packaging designed for peptide stability
  • Batch-tested for research-grade quality assurance
Dosage & Usage

Tirzepatide is referenced in scientific literature exploring:

  • Incretin receptor signaling pathways
  • Glucose and lipid metabolism research models
  • Comparative studies of dual vs. single-incretin agonism
  • Peptide stability and formulation research

Handling & Storage

Store at 2–6°C and protect from light. Keep out of reach of children. For research use only — handle in accordance with your facility's laboratory safety protocols and applicable regional regulations governing research compounds.

FAQ's & Tips

FAQs

Is this product intended for human use?

No. This product is sold strictly for laboratory and research purposes only, in line with applicable research-use regulations.

How should the vial be stored?

Store at 2–6°C, protected from light, until reconstitution. Refer to your institution's standard laboratory reconstitution and handling protocols.

Is authenticity verification available?

Yes — each box includes a scratch-and-scan panel allowing researchers to verify product authenticity directly with HD Laboratories.

Who is HD Labs?

HD Labs is a peptide manufacturer specializing in research-grade compounds, operating under licensed production standards. More information is available at hdlaboratories.com.

Research


As a dual-incretin agonist, Tirzepatide represents a departure from single-pathway GLP-1 compounds studied in earlier metabolic research. Its simultaneous activation of GIP and GLP-1 receptors has positioned it as a molecule of significant interest in academic and pharmaceutical research settings examining the interplay between these two incretin systems. Current research literature explores its effects on insulinotropic signaling, appetite-regulation pathways, and adipose tissue metabolism, with particular attention paid to how dual-receptor engagement may produce outcomes distinct from single-agonist compounds. Tirzepatide continues to be referenced across peer-reviewed studies investigating incretin-based approaches to metabolic and endocrine research.

Reviews